Correlation Between Monopar Therapeutics and Cellectis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Cellectis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Cellectis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Cellectis SA, you can compare the effects of market volatilities on Monopar Therapeutics and Cellectis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Cellectis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Cellectis.

Diversification Opportunities for Monopar Therapeutics and Cellectis

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Monopar and Cellectis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Cellectis SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectis SA and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Cellectis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectis SA has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Cellectis go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and Cellectis

If you would invest  244.00  in Monopar Therapeutics on September 4, 2024 and sell it today you would earn a total of  1,957  from holding Monopar Therapeutics or generate 802.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  Cellectis SA

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Cellectis SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectis SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Cellectis is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Monopar Therapeutics and Cellectis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and Cellectis

The main advantage of trading using opposite Monopar Therapeutics and Cellectis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Cellectis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will offset losses from the drop in Cellectis' long position.
The idea behind Monopar Therapeutics and Cellectis SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years